397 related articles for article (PubMed ID: 19190923)
1. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
Zhang Q; Zhang X; Sun A
Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
[TBL] [Abstract][Full Text] [Related]
2. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.
Lewis J; Dickson DW; Lin WL; Chisholm L; Corral A; Jones G; Yen SH; Sahara N; Skipper L; Yager D; Eckman C; Hardy J; Hutton M; McGowan E
Science; 2001 Aug; 293(5534):1487-91. PubMed ID: 11520987
[TBL] [Abstract][Full Text] [Related]
3. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles.
Wittmann CW; Wszolek MF; Shulman JM; Salvaterra PM; Lewis J; Hutton M; Feany MB
Science; 2001 Jul; 293(5530):711-4. PubMed ID: 11408621
[TBL] [Abstract][Full Text] [Related]
4. [Neurofibrillary tangles and early modification of the neuronal cytoskeleton in Alzheimer's disease and in experimental models].
Brion JP
Bull Mem Acad R Med Belg; 1999; 154(6 Pt 2):287-94. PubMed ID: 10992876
[TBL] [Abstract][Full Text] [Related]
5. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils.
Götz J; Chen F; van Dorpe J; Nitsch RM
Science; 2001 Aug; 293(5534):1491-5. PubMed ID: 11520988
[TBL] [Abstract][Full Text] [Related]
6. Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau.
Tanemura K; Akagi T; Murayama M; Kikuchi N; Murayama O; Hashikawa T; Yoshiike Y; Park JM; Matsuda K; Nakao S; Sun X; Sato S; Yamaguchi H; Takashima A
Neurobiol Dis; 2001 Dec; 8(6):1036-45. PubMed ID: 11741399
[TBL] [Abstract][Full Text] [Related]
7. The role of neurofibrillary tangles in Alzheimer disease.
Brion JP
Acta Neurol Belg; 1998 Jun; 98(2):165-74. PubMed ID: 9686275
[TBL] [Abstract][Full Text] [Related]
8. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein.
Lewis J; McGowan E; Rockwood J; Melrose H; Nacharaju P; Van Slegtenhorst M; Gwinn-Hardy K; Paul Murphy M; Baker M; Yu X; Duff K; Hardy J; Corral A; Lin WL; Yen SH; Dickson DW; Davies P; Hutton M
Nat Genet; 2000 Aug; 25(4):402-5. PubMed ID: 10932182
[TBL] [Abstract][Full Text] [Related]
9. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice.
Lucas JJ; Hernández F; Gómez-Ramos P; Morán MA; Hen R; Avila J
EMBO J; 2001 Jan; 20(1-2):27-39. PubMed ID: 11226152
[TBL] [Abstract][Full Text] [Related]
10. Biomedicine. Tauists and beta-aptists united--well almost!
Lee VM
Science; 2001 Aug; 293(5534):1446-7. PubMed ID: 11520974
[No Abstract] [Full Text] [Related]
11. Isoaspartate formation and neurodegeneration in Alzheimer's disease.
Shimizu T; Watanabe A; Ogawara M; Mori H; Shirasawa T
Arch Biochem Biophys; 2000 Sep; 381(2):225-34. PubMed ID: 11032409
[TBL] [Abstract][Full Text] [Related]
12. Neurodegenerative disease. Using the fruit fly to model tau malfunction.
Ferber D
Science; 2001 Jun; 292(5524):1983-4. PubMed ID: 11408629
[No Abstract] [Full Text] [Related]
13. Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice.
Ishihara T; Zhang B; Higuchi M; Yoshiyama Y; Trojanowski JQ; Lee VM
Am J Pathol; 2001 Feb; 158(2):555-62. PubMed ID: 11159192
[TBL] [Abstract][Full Text] [Related]
14. Abnormal tau-containing filaments in neurodegenerative diseases.
Crowther RA; Goedert M
J Struct Biol; 2000 Jun; 130(2-3):271-9. PubMed ID: 10940231
[TBL] [Abstract][Full Text] [Related]
15. Modeling Alzheimer's disease in transgenic mice.
Duff K
J Fla Med Assoc; 1994 Sep; 81(9):625-8. PubMed ID: 7964589
[TBL] [Abstract][Full Text] [Related]
16. Involvement of Activation of Asparaginyl Endopeptidase in Tau Hyperphosphorylation in Repetitive Mild Traumatic Brain Injury.
Hu W; Tung YC; Zhang Y; Liu F; Iqbal K
J Alzheimers Dis; 2018; 64(3):709-722. PubMed ID: 29889065
[TBL] [Abstract][Full Text] [Related]
17. Transneuronal degeneration in the spread of Alzheimer's disease pathology: immunohistochemical evidence for the transmission of tau hyperphosphorylation.
Su JH; Deng G; Cotman CW
Neurobiol Dis; 1997; 4(5):365-75. PubMed ID: 9440125
[TBL] [Abstract][Full Text] [Related]
18. Reversal by desferrioxamine of tau protein aggregates following two days of treatment in aluminum-induced neurofibrillary degeneration in rabbit: implications for clinical trials in Alzheimer's disease.
Savory J; Huang Y; Wills MR; Herman MM
Neurotoxicology; 1998 Apr; 19(2):209-14. PubMed ID: 9553957
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of Alzheimer's disease and dementia.
Bugiani O
Rev Neurol (Paris); 1999; 155 Suppl 4():S28-32. PubMed ID: 10637935
[TBL] [Abstract][Full Text] [Related]
20. Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease.
Brion JP; Tremp G; Octave JN
Am J Pathol; 1999 Jan; 154(1):255-70. PubMed ID: 9916940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
